Lytix Biopharma AS (OSL:LYTIX)
Norway · Delayed Price · Currency is NOK 9.44
-0.06 (-0.63%)
Jan 13, 2026, 4:06 PM CET
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of 740.3 million as of January 13, 2026. Its market cap has increased by 90.26% in one year.
Market Cap
740.30M
Enterprise Value
652.73M
Revenue
377.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
9.44
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has increased from 720.55M to 740.30M, an increase of 2.74%. That is a compound annual growth rate of 0.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 740.30M | 9.77% |
| Dec 30, 2025 | 674.43M | 68.03% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
| Jun 14, 2021 | 720.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.74B |
| Nordhealth AS | 2.83B |
| Photocure ASA | 2.02B |
| Thor Medical ASA | 1.83B |
| ArcticZymes Technologies ASA | 1.25B |
| Omda AS | 982.32M |
| Vistin Pharma ASA | 931.24M |
| Gentian Diagnostics ASA | 894.50M |